Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Published:2014-12-15 Issue:1 Volume:125 Page:386-402
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Jiang Changtao,Xie Cen,Li Fei,Zhang Limin,Nichols Robert G.,Krausz Kristopher W.,Cai Jingwei,Qi Yunpeng,Fang Zhong-Ze,Takahashi Shogo,Tanaka Naoki,Desai Dhimant,Amin Shantu G.,Albert Istvan,Patterson Andrew D.,Gonzalez Frank J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference68 articles.

1. Non-alcoholic fatty liver disease

2. Treatment of Non-Alcoholic Fatty Liver Disease

3. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

4. Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace

5. Gut Microbiota and Clinical Disease: Obesity and Nonalcoholic Fatty Liver Disease

Cited by 544 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An insoluble cellulose nanofiber with robust expansion capacity protects against obesity;International Journal of Biological Macromolecules;2024-10

2. Dietary bile acids have a differential role in preventing enteritis in juvenile grass carp, Ctenopharyngodon idella;Aquaculture Reports;2024-10

3. Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism;Acta Pharmaceutica Sinica B;2024-09

4. Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review;Nutrients;2024-08-24

5. High-fat feeding drives the intestinal production and assembly of C _16:0 ceramides in chylomicrons;Science Advances;2024-08-23